Delayed reporting of adverse events in Chinese investigator-initiated trials raising questions. 'Thing that bothers me is the lack of transparency.'
Schwartz is the third CDC nominee since Trump took office. CDC has lacked a permanent director since Susan Monarez was fired last August.
Experts reconsider how prostate cancer is diagnosed as a way to reduce unnecessary treatments. Under consideration: more MRIs, fewer biopsies.
Some participants in an early-stage clinical trial showed improved tolerance to peanuts after fecal microbiome transplant, according to a new study.
Sen. Ron Wyden, D-Ore., asks Health Secretary Kennedy for details on the timing of large donations that seem to coincide with favorable industry rulings.
Drugmakers are pressing CMS to keep ‘orphan’ therapies out of pilot programs, known as GUARD and GLOBE, to lower prices.
The training pipeline for physicians still runs on two tracks: one for M.D.s, one for D.O.s. That needs to change.
Pedro Almodóvar’s 'The Room Next Door' may have helped New York legalize assisted suicide.
Play: What's the word? Test your knowledge with today's mini crossword
